Newsletter | 01 September 2003 Access News 9, Focus on South Africa, September 2003 INTELLECTUAL PROPERTY AND TRADE This editions focus is on South Africa and the changing times, understanding patents, the Free Trade Area of the Americas, the ups and downs of the pharma industry and the G8s betrayal of people in developing countries. Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePress releaseReportResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Letter Letter | 13 July 2023 HIV/AIDS Intellectual property and trade Colombia CSO letter supporting Resolution 881/23 by Colombia on issuing a compulsory license for HIV drug dolutegravir Letter | 11 July 2023 Intellectual property and trade Tuberculosis Belarus Belarus: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis Letter Letter | 11 July 2023 Intellectual property and trade Tuberculosis Open Letter: Urgent action necessary for equitable access to bedaquiline in all countries with high burdens of TB, MDR-TB, and TB/HIV Photo credit: Abhinav Chatterjee/MSF Statement Statement | 12 June 2023 Pandemic preparedness Intellectual property and trade Pandemic Accord: MSF statement on INB Bureau’s text 2 min Events Events | 24 May 2023 Intellectual property and trade Tropical & neglected diseases Event: Ensuring equity in pandemics: Lessons learnt from Ebola therapeutics R&D and access constraints Photo credit: Ehab Zawati/MSF Press release Press release | 26 April 2023 Intellectual property and trade MSF responds to European Commission’s proposal to revise EU’s pharma legislation 3 min Technical brief | 07 April 2023 Pandemic preparedness Intellectual property and trade Pandemic Accord: MSF’s Comments on Equity Provisions in Zero Draft Photograph by Tadeu Andre Press release Press release | 14 March 2023 Intellectual property and trade United KingdomIndiaEuropean Union News Update: EU-India FTA negotiations could have negative impact on access to medicines 4 min Load More
Letter Letter | 13 July 2023 HIV/AIDS Intellectual property and trade Colombia CSO letter supporting Resolution 881/23 by Colombia on issuing a compulsory license for HIV drug dolutegravir
Letter | 11 July 2023 Intellectual property and trade Tuberculosis Belarus Belarus: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis
Letter Letter | 11 July 2023 Intellectual property and trade Tuberculosis Open Letter: Urgent action necessary for equitable access to bedaquiline in all countries with high burdens of TB, MDR-TB, and TB/HIV
Photo credit: Abhinav Chatterjee/MSF Statement Statement | 12 June 2023 Pandemic preparedness Intellectual property and trade Pandemic Accord: MSF statement on INB Bureau’s text 2 min
Events Events | 24 May 2023 Intellectual property and trade Tropical & neglected diseases Event: Ensuring equity in pandemics: Lessons learnt from Ebola therapeutics R&D and access constraints
Photo credit: Ehab Zawati/MSF Press release Press release | 26 April 2023 Intellectual property and trade MSF responds to European Commission’s proposal to revise EU’s pharma legislation 3 min
Technical brief | 07 April 2023 Pandemic preparedness Intellectual property and trade Pandemic Accord: MSF’s Comments on Equity Provisions in Zero Draft
Photograph by Tadeu Andre Press release Press release | 14 March 2023 Intellectual property and trade United KingdomIndiaEuropean Union News Update: EU-India FTA negotiations could have negative impact on access to medicines 4 min
